ADARx Pharmaceuticals, Inc. Common Stock (ADRX)

ADARx Pharmaceuticals, Inc. Common Stock (ADRX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: returns 1 day -0.3%, 1 week -0.1%.

ADARx Pharmaceuticals, Inc. (NASDAQ: ADRX) is a late-stage clinical biotechnology company focused on developing next-generation small interfering RNA (siRNA) therapeutics designed to address genetic, metabolic, cardiovascular, neurological, and complement-mediated diseases.

Groups ADRX belongs to

• Biotechnology
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Healthcare
• Biopharmaceutical
• Clinical Stage
• Life Sciences

ADRX financial model: income statement, cash flow and balance sheet